RxDoctor Payments Data

Donna Jaworski, PA

Physician Assistant · Buffalo, NYNPI 1982764312

Payments from drug & device makers

$4,500in general payments, 2019–2025

Across 272 payments — averaging $16.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$938
  • Mannkind Corporation$826
  • Lilly USA, LLC$440
  • AbbVie$305
  • AstraZeneca$294
  • Sanofi-aventis U.S. LLC$256
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$4,500100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,500 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$33,977
Medicare patients
59
Services billed
527

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban47$58,336
RybelsusSemaglutide11$22,839
JardianceEmpagliflozin26$21,062
XareltoRivaroxaban15$17,291
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$15,491
OzempicSemaglutide14$12,490
VascepaIcosapent Ethyl17$9,382
Praluent PenAlirocumab12$6,255
Fluticasone-SalmeterolFluticasone Propion/Salmeterol38$5,510
Levothyroxine Sodium297$5,381
Metoprolol Succinate241$5,006
Atorvastatin Calcium320$4,446
Lisinopril292$3,754
Ezetimibe133$3,148
SymbicortBudesonide/Formoterol Fumarate11$2,598

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$938$35,32825 claims
Boehringer IngelheimJardiance$113$21,06226 claims
GSKTrelegy Ellipta$105$15,49125 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$141$5,381297 claims
AstraZenecaSymbicort$294$2,59811 claims
AbbVieSynthroid$305$2,43741 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Buffalo

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →